PSORT Partners

PSORT Partner Representatives, 2017 Strategy Meeting, Royal College of Physicians, London

Internationally competitive expertise exists across the consortium between investigators and collaborators in all of the scientific disciplines required to successfully deliver the PSORT programme. We have developed an extensive network of pharmaceutical and diagnostic company partners who bring specific expertise and resources to the programme. Not only will this help in achieving the short term goals but it will also provide the necessary platform for translating the outcomes into clinically useful tests.

To achieve this goal, the PSORT consortium requires a number of important criteria to be met. Perhaps most importantly, we need consent from large numbers of patients to enter studies and provide samples of blood and skin. From the start of the study, we have engaged with the Psoriasis Association of Great Britain and Ireland (patient support organisation) to ensure the study met with their approval.

Consortium Partners

The University of Manchester
University of Liverpool
University of Newcastle
Kings College London
Queen Mary University of London
Guy’s and St Thomas’ NHS Foundation Trust
Abbvie
Beckton Dickinson
Celgene
GSK/Stiefel
Janssen
Medimmune
Novartis
Pfizer
Qiagen
Sanquin
British Association of Dermatologists
Centre for Addiction and Mental Health
Psoriasis Association
Royal College of Physicians